Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPreventive Services & ScreeningBCBS Kansas ACA Prevention Prior Auth | OpenPayer
    Ask Trek AI about this page
    ModifiedBlue Cross Blue Shield of KansasPolicy N/A

    ACA Prevention Copay Waiver Criteria - Individual Marketplace, Commercial

    Customize your policy alerts

    Sign up for all blue cross blue shield - kansas policy alerts

    Know when blue cross blue shield - kansas releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Prior authorization criteria for ACA preventive-service copay waivers for BCBSKS Individual Marketplace and commercial members, covering breast cancer prevention agents, contraceptives, HIV PrEP, and statins.

    Policy Summary
    PayerBlue Cross Blue Shield of Kansas
    PolicyACA Prevention Copay Waiver Criteria - Individual Marketplace, Commercial
    Policy CodePolicy N/A
    Change TypeModified
    Effective DateJune 15, 2026
    Last ReviewJun 15, 2026
    Next Review DateN/A
    Key ActionSubmit medical-necessity support and the information required to calculate ASCVD risk for statin requests.
    SourceLink
    POLICY UPDATE CHANGES

    Cabotegravir and Yeztugo were added to the PrEP agents addressed by the policy.

    Resources were added to the Clinical Rationale section.

    The empty Client Summary - Prior Authorization title was removed.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    4
    Preventive-service categories
    12 monthsBreast cancer prevention approval
    12 monthsContraceptive approval
    12 monthsHIV PrEP approval
    40-75Statin approval age range

    Preventive-Service Coverage Criteria

    Breast cancer primary prevention agent

    Covered when ALL of the following are met:

    • Core requirements: The requested agent is covered under the pharmacy benefit or approved through the coverage exception process; support is provided that it is medically necessary; the agent is tamoxifen, raloxifene, or an aromatase inhibitor (anastrozole, exemestane, or letrozole); the patient is 35 years of age or older; and the agent is requested for the primary prevention of breast cancer.Age >= 35 years
    • Sex-related requirement

      • No plan sex requirement: The plan has not implemented a sex requirement.
      • Plan sex requirement implemented

        • Sex-specific alternative: The patient's sex is female, or the requested agent is medically appropriate for the patient's sex.

    Contraceptives

    Covered when ALL of the following are met:

    Contraceptive agent: The requested contraceptive agent is covered under the pharmacy benefit or approved through the coverage exception process; is being used for contraception; and is supported as medically necessary.

    Approval length is 12 months.

    HIV infection pre-exposure prophylaxis (PrEP)

    Covered when ALL of the following are met:

    • Eligible PrEP agent: The requested PrEP agent is one of the following: a tenofovir disoproxil fumarate and emtricitabine combination ingredient agent; a tenofovir alafenamide and emtricitabine combination ingredient agent; cabotegravir; or Yeztugo (lenacapavir).
    • Clinical risk requirements: The patient has increased risk for HIV infection and has recently tested negative for HIV.Recent negative HIV test

    Primary prevention statin approval

    The requested statin will be approved when ALL of the following are met.

    Statin approval requirements

    • Generic availability: The requested agent is a generic statin (MSC=Y), unless a generic statin is not available for the requested agent.MSC=Y
    • Benefit eligibility: The requested statin is covered under the pharmacy benefit or approved through the coverage exception process.
    • Medical necessity: There is support that the requested statin is medically necessary.
    • Indication: The requested statin is for use in the primary prevention of cardiovascular disease (CVD).

    Key Approval Parameters

    Patient age
    Required age40-75 years inclusive
    Eligible usePrimary prevention of cardiovascular disease (CVD)
    Risk thresholdCalculated 10-year risk of a cardiovascular event of 10% or greater
    10-year ASCVD risk
    Minimum qualifying risk10% or greater
    Risk measureCalculated 10-year risk of a cardiovascular event
    Calculation methodAmerican College of Cardiology and American Heart Association's Atherosclerotic Cardiovascular Disease (ASCVD) calculator

    Authorization, Documentation, and Denial Guidance

    Prior Authorization

    Breast Cancer Prevention Prior Authorization

    Prior authorization approval requires that all applicable clinical criteria be satisfied before the requested breast cancer primary prevention agent is approved.

    • The agent is covered under the pharmacy benefit or approved through the coverage exception process.
    • The agent is medically necessary and is tamoxifen, raloxifene, or an aromatase inhibitor (anastrozole, exemestane, or letrozole).
    • The patient is at least 35 years of age and the agent is requested for primary prevention of breast cancer.
    • If the plan has a sex requirement, the patient must be female or the requested agent must be medically appropriate for the patient's sex.
    Prior Authorization

    Contraceptive Prior Authorization

    Prior authorization approval requires that all contraceptive coverage and clinical criteria be satisfied.

    • The contraceptive agent is covered under the pharmacy benefit or approved through the coverage exception process.

    Policy Purpose

    This policy establishes how an ACA preventive-service copay waiver, when available under the member’s benefit, is applied to eligible preventive products for the populations described by the USPSTF or HRSA. The waiver may allow an alternative recommended product to be provided without cost sharing when the provider determines that the covered $0 product is inappropriate for the individual and the alternative is medically necessary.

    Clinical Terms

    HIV infection pre-exposure prophylaxis (PrEP)
    DefinitionPre-exposure prophylaxis used to prevent HIV infection
    Intended populationPatients at increased risk for HIV infection
    HIV testing statusPatients who have recently tested negative for HIV
    ASCVD risk
    TermAtherosclerotic Cardiovascular Disease (ASCVD) risk
    PurposeRisk calculation required by the USPSTF recommendation
    CalculationCalculated using patient-specific cardiovascular risk information
    Policy Summary
    PayerBlue Cross Blue Shield of Kansas
    PolicyACA Prevention Copay Waiver Criteria - Individual Marketplace, Commercial
    Policy CodePolicy N/A
    Change TypeModified
    Effective DateJune 15, 2026
    Last ReviewJun 15, 2026
    Next Review DateN/A
    Key ActionSubmit medical-necessity support and the information required to calculate ASCVD risk for statin requests.
    SourceLink
    On This Page
    Preventive-Service Coverage CriteriaKey Approval ParametersAuthorization, Documentation, and Denial GuidancePolicy PurposeClinical Terms
  1. Age: The patient is 40-75 years of age, inclusive.40-75 years
  2. Qualifying risk factor

    • The patient has dyslipidemia.
    • The patient has diabetes.
    • The patient has hypertension.
    • The patient smokes.
  3. ASCVD risk threshold: The patient has a calculated 10-year risk of a cardiovascular event of 10% or greater using the American College of Cardiology and American Heart Association's Atherosclerotic Cardiovascular Disease (ASCVD) calculator.>=10%
  4. The agent is being used for contraception.
  5. The agent is medically necessary.
  6. Approval length is 12 months.
  7. Prior Authorization

    HIV PrEP Prior Authorization

    Prior authorization approval requires that all HIV infection pre-exposure prophylaxis (PrEP) coverage, clinical, and risk criteria be satisfied.

    • The PrEP agent is covered under the pharmacy benefit or approved through the coverage exception process and is being used for PrEP.
    • The agent is medically necessary and is an eligible tenofovir disoproxil fumarate/emtricitabine combination, tenofovir alafenamide/emtricitabine combination, cabotegravir, or Yeztugo (lenacapavir).
    • The patient has increased risk for HIV infection and has recently tested negative for HIV.
    Prior Authorization

    Statin Approval Criteria

    Prior authorization approval for the requested statin requires all operational and clinical criteria below.

    • The requested agent is a generic statin (MSC=Y), unless a generic statin is not available for the requested agent.
    • The statin is covered under the pharmacy benefit or approved through the coverage exception process and is medically necessary.
    • The statin is for primary prevention of cardiovascular disease (CVD).
    • The patient is 40–75 years of age, inclusive, and has at least one risk factor: dyslipidemia, diabetes, hypertension, or smoking.
    • The calculated 10-year cardiovascular event risk is at least 10% according to the American College of Cardiology/American Heart Association ASCVD calculator.
    • Approval length is 12 months; coverage is subject to the member's contract benefits in effect at the time of service.
    Documentation Required

    Breast Cancer Prevention Documentation

    Submit documentation sufficient to establish medical necessity and confirm the patient-specific breast cancer prevention criteria.

    • Requested agent and confirmation that it is tamoxifen, raloxifene, or anastrozole, exemestane, or letrozole.
    • Patient age and intended use for primary prevention of breast cancer.
    • Evidence that the agent is medically necessary.
    • Pharmacy benefit coverage or documentation of an approved coverage exception.
    • If applicable, the plan's sex requirement and the patient's sex or documentation that the agent is medically appropriate for the patient's sex.
    Documentation Required

    Contraceptive Documentation

    Submit documentation supporting the contraceptive indication and medical necessity for the requested agent.

    • Requested contraceptive agent and confirmation of pharmacy benefit coverage or an approved coverage exception.
    • Documentation that the agent is being used for contraception.
    • Medical-necessity documentation supporting the requested agent.
    Documentation Required

    HIV PrEP Documentation

    Submit documentation supporting PrEP use, medical necessity, eligible product selection, and the patient's HIV risk and testing status.

    • Requested PrEP agent and confirmation of pharmacy benefit coverage or an approved coverage exception.
    • Documentation that the agent is being used for HIV PrEP and is medically necessary.
    • The specific eligible agent: tenofovir disoproxil fumarate/emtricitabine, tenofovir alafenamide/emtricitabine, cabotegravir, or Yeztugo (lenacapavir).
    • Documentation that the patient has increased risk for HIV infection.
    • A recent negative HIV test result.
    Documentation Required

    Medical Necessity and ASCVD Risk Information

    Provide the information needed to support statin medical necessity and calculate the patient's 10-year ASCVD risk.

    • Patient sex, age, and race.
    • HDL cholesterol and total cholesterol.
    • Blood pressure and whether the patient is receiving hypertension treatment.
    • Whether the patient has diabetes.
    • Whether the patient is an active smoker.
    • Medical-necessity documentation, intended use for primary prevention of CVD, and applicable risk factors: dyslipidemia, diabetes, hypertension, or smoking.
    • The resulting 10-year ASCVD risk calculated with the American College of Cardiology/American Heart Association calculator.
    Denial Risk

    Breast Cancer Prevention Criteria Not Met

    Approval may be denied when any required breast cancer prevention criterion is not met or cannot be documented.

    • The agent is not covered under the pharmacy benefit and has not been approved through the coverage exception process.
    • Medical necessity is not supported, the agent is not an eligible product, the patient is younger than 35, or the request is not for primary prevention of breast cancer.
    • Where the plan has a sex requirement, the patient is not female and the agent is not medically appropriate for the patient's sex.
    Denial Risk

    Contraceptive Criteria Not Met

    Approval may be denied when any required contraceptive criterion is not met or cannot be documented.

    • The agent is not covered under the pharmacy benefit and has not been approved through the coverage exception process.
    • The agent is not being used for contraception.
    • Medical necessity for the requested contraceptive agent is not supported.
    Denial Risk

    HIV PrEP Criteria Not Met

    Approval may be denied when any required HIV PrEP criterion is not met or cannot be documented.

    • The agent is not covered under the pharmacy benefit and has not been approved through the coverage exception process, or the request is not for PrEP use.
    • Medical necessity is not supported or the requested agent is not one of the eligible PrEP agents.
    • The patient does not have increased risk for HIV infection or has not recently tested negative for HIV.
    Denial Risk

    Statin Criteria Not Met

    Approval may be denied when any required statin criterion is not met or cannot be documented.

    • The requested agent is not a generic statin and a generic statin is available.
    • The statin is not covered under the pharmacy benefit and has not been approved through the coverage exception process, or medical necessity is not supported.
    • The request is not for primary prevention of CVD, the patient is outside the 40–75 age range, or none of the listed risk factors is present.
    • The calculated 10-year ASCVD cardiovascular event risk is below 10% or cannot be calculated from the required patient information.
    ASCVD risk calculation inputs
    Patient characteristicsSex, age, and race
    Laboratory informationHigh density lipoprotein (HDL) cholesterol and total cholesterol
    Clinical factorsBlood pressure, diabetes status, hypertension-treatment status, and active-smoking status